Skip to content

AGEN

Agenus Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.26
+0.18%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue132.7M114.2M103.5M156.3M98.0M
Cost of Revenue32.3M80.4M156.0M237.7M197.3M
Gross Profit100.4M33.8M(52.6M)(81.4M)(99.2M)
Operating Expenses
R&D Expense26.6M155.5M234.6M
SG&A Expense38.5M54.4M71.9M78.7M81.0M
General & Admin Expense38.5M54.4M71.9M78.7M81.0M
Selling & Marketing Expense
Other Expenses(901.0K)(159.5M)(235.1M)(815.0K)
Total Operating Expenses64.2M54.4M67.9M78.2M80.2M
Cost and Expenses96.5M134.8M223.9M315.9M277.5M
Operating Income (EBIT)36.2M(20.6M)(120.5M)(159.5M)(179.4M)
Non-Operating
Interest Income21.0K
Interest Expense59.1M55.3M117.6M97.9M61.9M
Net Interest Income(59.1M)(55.3M)(117.6M)(97.9M)(61.9M)
Other Non-Op Income/Expense55.7M17.5M(111.8M)(97.9M)(51.2M)
Non-Operating Income (excl Interest)(114.9M)(72.7M)(5.8M)(37.0K)(10.6M)
EBT (Pre-Tax Income)91.9M(3.1M)(232.3M)(257.4M)(230.7M)
Income Tax Expense
Bottom Line
Net Income92.0M115.0K(227.2M)(245.8M)(220.1M)
Earnings from Cont. Ops91.9M(3.1M)(232.3M)(257.4M)(230.7M)
Earnings from Discont. Ops
Bottom Line Net Income91.8M(101.0K)(227.4M)(246.0M)(220.3M)
Per Share
Basic EPS$2.72($0.00)($10.59)($13.75)($15.64)
Diluted EPS$2.65($0.00)($10.59)($13.75)($15.64)
Revenue Per Share$3.21$3.84$4.82$8.74$6.96
Shares
Basic Shares Outstanding41.3M29.7M21.5M17.9M14.1M
Diluted Shares Outstanding41.3M29.7M21.5M17.9M14.1M
Profitability Metrics
EBITDA155.8M62.2M(101.3M)(145.9M)(161.8M)
D&A4.7M10.0M13.3M13.6M6.9M
EBIT151.1M52.2M(114.6M)(159.5M)(168.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026